Wellington Partners Unveils €210m Eurocentric Biotech/Medtech Fund WPLS-V
Executive Summary
With its WPLS-IV fund now fully committed, Wellington Partners has returned to the market and raised €210m in its WPLS-V fund which will focus on European biotech and medtech opportunities.
You may also be interested in...
LSP Closes Mega Life Sciences Fund For Europe, But US Still Way Ahead
A new life sciences fund, LSP 6, is one of the largest fundraisings in Europe in the sector, and will invest in around 15-to-18 pharma or medtech companies.
Finance Watch: Cell And Gene Therapy Fundraising Down Overall In Q2, But VC Deals Still Soared
Private Company Edition: ARM's Q2 report shows a 38% decline in financings, but venture capital and upfront fees from deals were robust. Also, Servier raises $405m in the US, Frequency closes a $62m series C and VenatoRx accesses US government cash.
M&A Analysis: October Notches 30 Deals In Big M&A Boom
The medtech M&A deal count soared in October with a total of 30 deals announced and closed in the month. It was an especially busy month for the orthopedics sector, with a number of high profile deals inked.